Sandip I. Patel

Insider Reports History

Location
Tampa, FL
Signature
/s/ Torsten Hombeck, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandip I. Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
AtlasClear Holdings, Inc. Director Common Stock 243,194 $1,128,420 $4.64 09 Feb 2024 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 903,714,000 $1,084,457 $0.0012 14 Nov 2024 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 451,857 $506,080 $1.12 20 Mar 2025 Direct
Akari Therapeutics Plc Director Series A Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct
Akari Therapeutics Plc Director Series B Warrants (Right to Buy) 44,642 $49,999 $1.12 06 Mar 2025 Direct
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 40,438,000 $48,526 $0.0012 14 Nov 2024 By Davis Island Ventures LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 39,760,000 $47,712 $0.0012 14 Nov 2024 By Quest Bio LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 27,802,000 $33,362 $0.0012 14 Nov 2024 By Innovative Lifesci Investments LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 20,219 $22,645 $1.12 25 Apr 2025 Davis Island Ventures LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 19,880 $22,266 $1.12 25 Apr 2025 Quest Bio LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13,901 $15,569 $1.12 20 Mar 2025 Innovative Lifesci Investment LLC
Akari Therapeutics Plc Director Ordinary Shares, par value $0.0001 per share 12,500,000 $15,000 $0.0012 14 Nov 2024 By TT Insurance Investment LLC
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 6,250 $7,000 $1.12 25 Apr 2025 TT Insurance Investment LLC
Peak Bio, Inc. Director Common Stock 0 $0 $0.265 14 Nov 2024 Direct
Peak Bio, Inc. Director Common Stock 0 $0 $0.265 14 Nov 2024 Indirect
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 1,417,500 09 Mar 2023 Indirect
AtlasClear Holdings, Inc. Director Warrants 354,088 20 Mar 2024 Direct
Akari Therapeutics Plc Director Stock Option (Right to Buy) 225,000 20 Mar 2025 Direct
Monterey Innovation Acquisition Corp Director, 10%+ Owner Common Stock 35,000 09 Mar 2023 Direct
Akari Therapeutics Plc Director American Depositary Shares representing Ordinary Shares 13,901 25 Apr 2025 Innovative Lifesci Investments LLC
Peak Bio, Inc. Director Convertible Notes 0 14 Nov 2024 Direct
Peak Bio, Inc. Director Stock Option (Right to Buy) 0 14 Nov 2024 Direct
Quantum FinTech Acquisition Corp Director Common Stock 0 09 Feb 2024 Direct

Insider Reports Filed by Sandip I. Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKTX Akari Therapeutics Plc 25 Apr 2025 3 $149,997 4 Director 29 Apr 2025, 17:00
AKTX Akari Therapeutics Plc 20 Mar 2025 2 $0 4 Director 24 Mar 2025, 17:00
AKTX Akari Therapeutics Plc 14 Nov 2024 0 $0 3 Director 22 Nov 2024, 16:30
PKBO Peak Bio, Inc. 14 Nov 2024 7 -$275,500 4 Director 18 Nov 2024, 18:55
ATCH AtlasClear Holdings, Inc. 09 Feb 2024 2 $0 4 Director 16 Apr 2024, 17:26
ATCH AtlasClear Holdings, Inc. 09 Feb 2024 0 $0 3 Director 16 Apr 2024, 17:24
QFTA Quantum FinTech Acquisition Corp 09 Feb 2024 1 $0 4 Director 16 Feb 2024, 19:13
MTRY Monterey Innovation Acquisition Corp 09 Mar 2023 2 -$3,420 4 Director, 10%+ Owner 13 Mar 2023, 20:44
MTRY Monterey Bio Acquisition Corp 30 Sep 2021 0 $0 3 Director, 10%+ Owner 30 Sep 2021, 17:51